2011; 9: 218. doi: 10.1186/1479-5876-9-218.
67. Henning RJ, Abu-Ali H, Balis JU, Morgan MB, Willing AE, Sanberg
PR. Human umbilical cord blood mononuclear cells for the treatment of acute
myocardial infarction. Cell Transplant. 2004; 13(7-8): 729-39.
68. Stone LL, Xiao F, Rotshafer J, et al. Amelioration of ischemic brain
injury in rats with human umbilical cord blood stem cells: Mechanisms of action.
Cell Transplant. 2016 Mar 18. [Epub ahead of print]
69. Riordan NH, Ichim TE. Immune privilege of cord blood. In:
Bhattacharya N, Stubblefeld P, eds. Regenerative Medicine Using Pregnancy-
Specific Biological Substances. New York, NY: Springer; 2010: 307-319.
Chương 5
1. Stelnicki EJ, Chin GS, Gittes GK, Longaker MT. Fetal wound repair:
where do we go from here? Semin Pediatr Surg. 1999; 8(3): 124-30.
2. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991 Sep; 9(5): 641-
50.
3. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization,
differentiation, and homing. Arterioscler Thromb Vasc Biol. 2003; 23(7): 1185-9.
4. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and
role in vascular biology. Circ Res. 2004; 95: 343-353.
5. Watt SM, Gullo F, van der Garde M, et al. The angiogenic properties of
mesenchymal stem/stromal cells and their therapeutic potential. Br Med Bull.
2013; 108: 25-53. doi: 10.1093/bmb/ldt031.
6. Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol.
2009; 217(2): 318-24. doi: 10.1002/path.2469.
7. Alt EU, Senst C, Murthy SN, et al. Aging alters tissue resident
mesenchymal stem cell properties. Stem Cell Res. 2012 Mar; 8(2): 215-25. doi:
10.1016/j.scr.2011.11.002.
8. Chang HX, Yang L, Li Z, Chen G, Dai G. Age-related biological
characterization of mesenchymal progenitor cells in human articular cartilage.
